Important safety information for people with diabetes in possession of a GlucaGen庐 HypoKit 15 September 2016 Novo Nordisk Pharmaceuticals Pty Ltd is recalling 4 batches of GlucaGen HypoKit in Australia. The GlucaGen HypoKit is indicated for the 鈥榯reatment of severe hypoglycaemic reactions which may occur in the management of diabetic patients receiving insulin or oral hypoglycaemic agents鈥�. Novo Nordisk conducted an investigation showing a small number of needles were detached from the pre-filled syringe supplied in certain batches of the GlucaGen HypoKit. To protect patient safety, Novo Nordisk is recalling all products in the affected batches from wholesalers, pharmacies and patients in Australia. The recalled GlucaGen HypoKit batch numbers are: FS6X465 FS6X536 FS6X715 FS6X891 With expiry date: 31-Aug-2017 If you are in possession of a GlucaGen HypoKit with one of the listed batch numbers, return your GlucaGen HypoKit product to your pharmacy. You will be given a free replacement GlucaGen HypoKit. To view the original TGA announcement, please visit their website: If you have any questions regarding this recall, please contact NovoCare Customer Care Centre on 1800 668 626 for further information.
Partners 29 April 2026 What should I eat for type 2 diabetes? Sponsored by Defeat Diabetes If you鈥檝e been diagnosed with type 2 diabetes, one of the first questions that comes up... Continue Reading
Blog 22 April 2026 Here鈥檚聽what happens when聽lived experience becomes a movement聽聽 Meet the Blue Circle Collective 鈥� a national network of Ambassadors, Advocates, and Advisers united to drive meaningful change for all Australians. What is... Continue Reading
Media releases 20 April 2026 SA shoppers – check your health while you check your fit聽 Shoppers at selected Target stores in South Australia can now take five from checking out the latest fashion fits to... Continue Reading
